Dr. Floyd Bloom Joins aTyr Pharma's Scientific Advi...(mmel co-founder of aTyr Pharma fellow Na...)

Date:10/14/2009

mmel, co-founder of aTyr Pharma, fellow National Academy member and Professor at the Scripps Research Institute added, "I have known, respected and admired Dr. Bloom's integrity and scientific excellence for decades. Dr. Bloom's unparalleled expertise brings additional scientific authority to what was already a world class scientific advisory board at aTyr Pharma. Dr. Bloom's influence and guidance, will help us accelerate our understanding and development of aTyr Pharma's novel class of therapeutic proteins."

About Dr. Bloom

After receiving an A. B., cum laude, from Southern Methodist University, Dr. Bloom went on to receive his M. D. cum laude from the Washington university School of Medicine before completing a residency and internship at the Barnes-Jewish Hospital. His scientific career has led to a number of key leadership positions such as Director of Behavioral Neurobiology at the Salk Institute for Biological Studies, Chief of the Laboratory of Neuropharmacology at the National Institute of Mental Health, Chair Emeritus of the Department of Neuropharmacology at The Scripps Research Institute. Awards and recognition of his scientific skills and contributions to society include 6 honorary doctorates, the Pasarow Award in Neuropsychiatry, the Hermann van Helmholz Award, the Sarnat Award for Mental Health Research and his election to prestigious societies such as the National Academy of Sciences, the Institute of Medicine, the American Philosophical Society and the Royal Swedish Academy of Science. Demonstrating a broad commitment to the advancement of science, Dr. Bloom has been the editor-in-chief of Science, arguably one of the highest impact scientific journals in the world, and has also served as President of the American Association for the Advancement of Science. One of the most influential scientists in the world, Dr. Bloom has authored or co-authored over 400 research articles, 29 monographs, over 250 solicited
'/>"/>

SOURCE aTyr Pharma, Inc. Copyright©2009 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3
Related biology technology :

1. Imagenetix, Inc. Announces Interview With Bloomberg Radio
2. BioMarin Corrects Information Included in Bloomberg Article
3. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiographic Data Safety Monitoring Board Review
4. Arena Pharmaceuticals Continues Phase 3 BLOOM Obesity Trial Following Independent Echocardiogaphic Data Safety Monitoring Board Review
5. Dr. Michael Merzenich Joins Venerable Short List Honored for Cutting-Edge Neuroscientific Research
6. Barby K. Siegel Joins Zeno Group as Chief Executive Officer
7. LASIK Surgery Specialist G. Brock Magruder, Jr., M.D. of LaserVue Lasik Center of Orlando Joins the Trusted LASIK Surgeons Directory
8. Sanford Rose Associates Joins the International Executive Search Federation
9. Christopher Brennan Joins PharmaNet Development Group as General Counsel
10. Richard Gephardt Joins Leading Innovators in Washington State to Call for Greater Focus on Policies to Boost Economy and Maintain U.S. Competitiveness in Medical Science and Innovation
11. John J. Young, Jr. Joins SRI Board of Directors